Oral contraceptives: considerations of safety in nonclinical distribution.
作者信息
Atkinson L, Castadot R, Cuadros A, Rosenfield A G
出版信息
Stud Fam Plann. 1974 Aug;5(8):242-9.
PMID:4602364
Abstract
摘要
相似文献
1
Oral contraceptives: considerations of safety in nonclinical distribution.口服避孕药：非临床分发中的安全性考量
Stud Fam Plann. 1974 Aug;5(8):242-9.
2
Thromboembolism, cancer, and oral contraceptives.
Clin Obstet Gynecol. 1974 Mar;17(1):65-78. doi: 10.1097/00003081-197403000-00009.
3
[Peroral contraceptives and thromboembolism].[口服避孕药与血栓栓塞]
Lijec Vjesn. 1969 Jul;91(7):779-82.
4
[Hormonal contraception and blood coagulation disorders].
Med Klin. 1974 Feb 15;69(7):265-71.
5
Evaluation of rare adverse effects of systemic contraceptives.
Br Med Bull. 1970 Jan;26(1):33-8. doi: 10.1093/oxfordjournals.bmb.a070740.
6
Oral contraceptive steroids and malignancy.
Clin Oncol. 1982 Jun;8(2):97-102.
7
Complications of the contraceptive pill.
Wis Med J. 1970 Feb;69(2):84-91.
8
Monitoring side effects of contraceptives.
Acta Endocrinol Suppl (Copenh). 1974;185:279-95. doi: 10.1530/acta.0.075s279.
9
Cancer risks from estrogen intake.
N Y State J Med. 1977 Jun;77(7):1069-74.
10
An analysis of the reported association of oral contraceptives to thromboembolic disease.关于口服避孕药与血栓栓塞性疾病之间所报道关联的分析。
West J Med. 1975 Jan;122(1):26-33.
Zotero 插件